# Nivagen Pharmaceuticals, Inc. – FDA Inspection, Nov 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/nivagen-pharmaceuticals-inc/cf016f93-e4b9-4ee0-b12b-35d63a7739ee
Source feed: FDA_Inspections

> FDA inspection 1254791 of Nivagen Pharmaceuticals, Inc., November 22, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254791
- Company Name: Nivagen Pharmaceuticals, Inc.
- Inspection Date: 2024-11-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 4

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/saied-a-asbagh/215bfa90-995f-4310-baf3-cd9d37639b7b)

Company: https://www.keypedia.com/companies/nivagen-pharmaceuticals-inc/13758ef9-a807-493e-a164-7442675b09a0

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df